PRAP1 and colorectal carcinoma: The above data show that overexpression of PRAP1 in normal HCT-116 cells results in a drug-resistant phenotype, but PRAP1 downregulation in HCT-116/DDP cells promotes the sensitivity of CRC cells to chemotherapeutic drugs.